Despite the short treatment duration , both RO-151 and RO-838 showed trends for improved HbA1c and consistent reductions in body weight ( -0.86 to -1.67 kg ) exceeding those observed with placebo ( -0.28 kg , p = 0.019 for 200 mg RO-151 vs. placebo ) .